176 related articles for article (PubMed ID: 34170978)
1. Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
Nguyen THP; Fagerland MW; Deyab G; Hjeltnes G; Hollan I; Feinberg MW; Eilertsen GØ; Mikkelsen K; Agewall S
PLoS One; 2021; 16(6):e0253793. PubMed ID: 34170978
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT
Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107
[TBL] [Abstract][Full Text] [Related]
3. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
[TBL] [Abstract][Full Text] [Related]
4. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis.
Solus J; Chung CP; Oeser A; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
Arthritis Rheum; 2008 Sep; 58(9):2662-9. PubMed ID: 18759301
[TBL] [Abstract][Full Text] [Related]
5. NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study.
Moraes JC; Ribeiro AC; Saad CG; Lianza AC; Silva CA; Bonfá E
Clin Rheumatol; 2013 Jun; 32(6):879-83. PubMed ID: 23381669
[TBL] [Abstract][Full Text] [Related]
6. Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study.
Raadsen R; Dijkshoorn B; van Boheemen L; Ten Boekel E; van Kuijk AWR; Nurmohamed MT
Joint Bone Spine; 2024 May; 91(3):105683. PubMed ID: 38161051
[TBL] [Abstract][Full Text] [Related]
7. Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.
Bissell LA; Hensor EM; Kozera L; Mackie SL; Burska AN; Nam JL; Keen H; Villeneuve E; Donica H; Buch MH; Conaghan PG; Andrews J; Emery P; Morgan AW
Rheumatology (Oxford); 2016 Dec; 55(12):2181-2190. PubMed ID: 27638812
[TBL] [Abstract][Full Text] [Related]
8. [Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment].
Gerasimova EV; Popkova TV; Martynova AV; Markelova EI; Novikova DS; Kirillova IG
Ter Arkh; 2019 May; 91(5):34-39. PubMed ID: 32598674
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator.
Bradham WS; Ormseth MJ; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
Inflammation; 2014 Jun; 37(3):801-8. PubMed ID: 24402421
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K
J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935
[TBL] [Abstract][Full Text] [Related]
12. The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study.
Provan SA; Angel K; Odegård S; Mowinckel P; Atar D; Kvien TK
Arthritis Res Ther; 2008; 10(3):R70. PubMed ID: 18573197
[TBL] [Abstract][Full Text] [Related]
13. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L; Yaping L; Xiufen H
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
[TBL] [Abstract][Full Text] [Related]
14. Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis.
Targońska-Stępniak B; Majdan M
Clin Rheumatol; 2011 Jan; 30(1):61-9. PubMed ID: 21110214
[TBL] [Abstract][Full Text] [Related]
15. Function of N-terminal pro-brain natriuretic peptide in Takayasu arteritis disease monitoring.
Liu Q; Dang A; Chen B; Lv N; Wang X; Zheng D
J Rheumatol; 2014 Aug; 41(8):1683-8. PubMed ID: 25028376
[TBL] [Abstract][Full Text] [Related]
16. The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
Podlecka-Piętowska A; Kochanowski J; Zakrzewska-Pniewska B; Opolski G; Kwieciński H; Kamińska AM
Neurol Neurochir Pol; 2014; 48(2):111-5. PubMed ID: 24821636
[TBL] [Abstract][Full Text] [Related]
17. Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Deyab G; Hokstad I; Whist JE; Småstuen MC; Agewall S; Lyberg T; Bottazzi B; Meroni PL; Leone R; Hjeltnes G; Hollan I
PLoS One; 2017; 12(2):e0169830. PubMed ID: 28225768
[TBL] [Abstract][Full Text] [Related]
18. Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.
Nguyen THP; Hokstad I; Fagerland MW; Mollnes TE; Hollan I; Feinberg MW; Hjeltnes G; Eilertsen GØ; Mikkelsen K; Agewall S
PLoS One; 2022; 17(2):e0264628. PubMed ID: 35213675
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of N-terminal pro-brain natriuretic peptide and C-reactive protein to predict ICU mortality in unselected medical ICU patients: a prospective, observational study.
Wang F; Pan W; Pan S; Wang S; Ge Q; Ge J
Crit Care; 2011; 15(1):R42. PubMed ID: 21272380
[TBL] [Abstract][Full Text] [Related]
20. NT-proBNP and sRAGE levels in early rheumatoid arthritis.
Heslinga M; Teunissen C; Agca R; van der Woude D; Huizinga T; van Laar J; den Broeder A; Lems W; Nurmohamed M
Scand J Rheumatol; 2023 May; 52(3):243-249. PubMed ID: 35274588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
